相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis
Sabine Klein et al.
GUT (2017)
Rifaximin Has No Effect on Hemodynamics in Decompensated Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Nina Kimer et al.
HEPATOLOGY (2017)
Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis
Gaeun Kim et al.
GUT AND LIVER (2017)
The Anticoagulant Rivaroxaban Lowers Portal Hypertension in Cirrhotic Rats Mainly by Deactivating Hepatic Stellate Cells
Marina Vilaseca et al.
HEPATOLOGY (2017)
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
Philipp Schwabl et al.
JOURNAL OF HEPATOLOGY (2017)
Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
Gaeun Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
The need for histological subclassification of cirrhosis: a systematic review and meta-analysis
Gaeun Kim et al.
LIVER INTERNATIONAL (2016)
The Complex Role of Anticoagulation in Cirrhosis: An Updated Review of Where We Are and Where We Are Going
Tawfik Khoury et al.
DIGESTION (2016)
Transplantation With Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial
Ki Tae Suk et al.
HEPATOLOGY (2016)
Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review
Gaeun Kim et al.
HEPATOLOGY INTERNATIONAL (2016)
Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats
Federica Cerini et al.
JOURNAL OF HEPATOLOGY (2016)
Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis
Yoon Ok Jang et al.
STEM CELLS TRANSLATIONAL MEDICINE (2016)
Acute kidney injury in liver cirrhosis: new definition and application
Florence Wong
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation
Ji Hye Jun et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2016)
Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study
Enric Reverter et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study
Wolfgang Kreisel et al.
DIGESTIVE AND LIVER DISEASE (2015)
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
Roberto de Franchis
JOURNAL OF HEPATOLOGY (2015)
Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis
Gaeun Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis
De-Run Kong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
Young Woo Eom et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Mesenchymal stem cell therapy for liver fibrosis
Young Woo Eom et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation
Tian Lan et al.
PLOS ONE (2015)
Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
Sabine Klein et al.
PLOS ONE (2015)
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
Yoon Ok Jang et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2015)
Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
Yoon Ok Jang et al.
BMC GASTROENTEROLOGY (2014)
Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis
Michaela Granzow et al.
HEPATOLOGY (2014)
PDE5 inhibitor efficacy is estrogen dependent in female heart disease
Hideyuki Sasaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions
Yasuko Iwakiri et al.
JOURNAL OF HEPATOLOGY (2014)
Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
Won Ki Hong et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Histological improvement following administration of autologous bone marrow-derived mesenchymal stemcells for alcoholic cirrhosis: a pilot study
Yoon Ok Jang et al.
LIVER INTERNATIONAL (2014)
Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
Jae Hyun Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2014)
Terutroban, a TP-Receptor Antagonist, Reduces Portal Pressure in Cirrhotic Rats
Eugenio Rosado et al.
HEPATOLOGY (2013)
Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
Jiannis Vlachogiannakos et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats
Maeva Guillaume et al.
JOURNAL OF HEPATOLOGY (2013)
Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial
Nitin Gupta et al.
LIVER INTERNATIONAL (2013)
Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-β1
Xiaobao Fan et al.
PLOS ONE (2013)
The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study
M. Pinter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis
Moon Young Kim et al.
HEPATOLOGY (2012)
Functional aspects on the pathophysiology of portal hypertension in cirrhosis
Juan-Carlos Garcia-Pagan et al.
JOURNAL OF HEPATOLOGY (2012)
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study
Moon Young Kim et al.
LIVER INTERNATIONAL (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response
Yiannis N. Kallis et al.
GUT (2011)
Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis
Yanfei Chen et al.
HEPATOLOGY (2011)
Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability
Kuei-Chuan Lee et al.
CLINICAL SCIENCE (2010)
Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study
Andre Castro Lyra et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis
Puneeta Tandon et al.
JOURNAL OF HEPATOLOGY (2010)
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
Jonel Trebicka et al.
JOURNAL OF HEPATOLOGY (2010)
Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a review
Soon Koo Baik
LIVER INTERNATIONAL (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
Haemodynamic and renal effects of tadalafil in patients with cirrhosis
Georgios N. Kalambokis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
J. Vlachogiannakos et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
John S. Lubel et al.
CLINICAL SCIENCE (2009)
Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis
Moon Young Kim et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Beneficial Effects of Sorafenib on Splanchnic, Intrahepatic, and Portocollateral Circulations in Portal Hypertensive and Cirrhotic Rats
Marc Mejias et al.
HEPATOLOGY (2009)
Angiogenesis in liver disease
Mercedes Fernandez et al.
JOURNAL OF HEPATOLOGY (2009)
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Philippe Lefebvre et al.
PHYSIOLOGICAL REVIEWS (2009)
Irbesartan plus low-dose propranolol Versus low-dose propranolol alone in cirrhosis:: A placebo-controlled, double-blind study
Michael Schepke et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding
Gin-Ho Lo et al.
HEPATOLOGY (2008)
Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model
Moon Young Kim et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats
Vasilica Matei et al.
JOURNAL OF HEPATOLOGY (2008)
Increased oxidative stress in cirrhotic rat livers:: A potential mechanism contributing to reduced nitric oxide bioavailability
Jorge Gracia-Sancho et al.
HEPATOLOGY (2008)
FXR-mediated regulation of eNOS expression in vascular endothelial cells
Jiang Li et al.
CARDIOVASCULAR RESEARCH (2008)
Effect of Propranolol on Portal Pressure and Systemic Hemodynamics in Patients with Liver Cirrhosis and Portal Hypertension: A Prospective Study
Ki Tae Suk et al.
GUT AND LIVER (2007)
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
Jonel Trebicka et al.
HEPATOLOGY (2007)
Shattuck Lecture: Nitric oxide and cyclic GMP in cell signaling and drug development
Ferid Murad
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hematopoietic stem cells - The paradigmatic tissue-specific stem cell
David Bryder et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis
Vasilica Matei et al.
HEPATOLOGY (2006)
Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers
MR Loureiro-Silva et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatic guanylate cyclase activity is decreased in a model of cirrhosis: A quantitative cytochemistry study
NA Davies et al.
FEBS LETTERS (2006)
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
M Hernández-Guerra et al.
HEPATOLOGY (2006)
The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule
Y Iwakiri et al.
HEPATOLOGY (2006)
Oxidative stress and signal transduction pathways in alcoholic liver disease
T Zima et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2005)
Bacterial translocation (BT) in cirrhosis
R Wiest et al.
HEPATOLOGY (2005)
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis
SJ Forbes et al.
GASTROENTEROLOGY (2004)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity
SK Baik et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers
M Graupera et al.
HEPATOLOGY (2003)
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
J González-Abraldes et al.
GASTROENTEROLOGY (2001)
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
R Bataller et al.
GASTROENTEROLOGY (2000)
分享论文
